Anondita Medicare IPO allotment: After 300x subscription, Anondita Medicare IPO allotment out today. Check Status, GMP and other details – News Air Insight

Spread the love


The allotment for the Rs 69.5 crore IPO of Anondita Medicare is expected to be finalised today. Investors who applied for the IPO will soon be able to check whether they have received shares once the allotment link is out.

Check GMP on allotment day

As of now, the grey market premium for Anondita Medicare IPO is indicating strong signals with 55% GMP. Market watchers suggest that the stock may see healthy listing gains.

Strong subscription for IPO

The issue, which opened on August 22 and closed on August 26, was subscribed over 300 times overall, making it one of the most sought-after SME IPOs this year.

The retail portion was subscribed 286.20 times, non-institutional investors bid 531.82 times, while the qualified institutional buyer (QIB) category saw 153.03 times subscription. In all, the IPO received over 2.88 lakh applications.


How to check Anondita Medicare IPO allotment statusOnce the allotment is finalized, investors can check their application status in two ways:1. On the registrar’s website (Maashitla Securities):

Visit Maashitla Securities (https://maashitla.com/allotment-status/public-issues)

Click on Equity

Enter PAN or application number

2. On NSE website:

Visit official NSE website (https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids)

Click on Equity

Investors will need to enter details such as PAN, application number.

What next for the IPO?

Refunds for those who did not get shares will be initiated on August 29. Shares allotted will be credited to investors’ demat accounts on the same day. Anondita Medicare is set to list on NSE SME on Monday.

Company background

Anondita Medicare manufactures flavored male condoms and recently expanded into female condoms. The company has an annual production capacity of 562 million units at its Noida facility and exports to Southeast Asia, Africa, and the Middle East.

The Noida-based company manufactures male condoms under the “COBRA” brand and also supplies to global health organisations.

For FY25, the company reported a 327% jump in profit after tax to Rs 16.42 crore on revenues of Rs 77.13 crore.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *